accountLOS ANGELES (MarketWatch) �� U.S.-listed shares of GlaxoSmithKline Plc rose Tuesday evening following reports that a regulatory panel has recommended for approval the drugmaker��s jointly development treatment for lupus. Glaxo shares...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo taken up after hours
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account